Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.

Bolton-Gillespie, Elisabeth; Schemionek, Mirle; Klein, Hans-Ulrich; Flis, Sylwia; Hoser, Grazyna; Lange, Thoralf; Nieborowska-Skorska, Margaret; Maier, Jacqueline; Kerstiens, Linda; Koptyra, Mateusz; Müller, Martin C; Modi, Hardik; Stoklosa, Tomasz; Seferynska, Ilona; Bhatia, Ravi; Holyoake, Tessa L; Koschmieder, Steffen; Skorski, Tomasz

Bolton-Gillespie, Elisabeth; Schemionek, Mirle; Klein, Hans-Ulrich; Flis, Sylwia; Hoser, Grazyna; Lange, Thoralf; Nieborowska-Skorska, Margaret; Maier, Jacqueline; Kerstiens, Linda; Koptyra, Mateusz; Müller, Martin C; Modi, Hardik; Stoklosa, Tomasz; Seferynska, Ilona; Bhatia, Ravi; Holyoake, Tessa L; Koschmieder, Steffen; Skorski, Tomasz.

Affiliation

Bolton-Gillespie E; Department of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, PA 19140, USA.

Blood ; 121(20): 4175-83, 2013 May 16.

Article in En | MEDLINE | ID: mdl-23543457

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Neoplastic Stem Cells / Benzamides / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Drug Resistance, Neoplasm / Genomic Instability / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Blood Year: 2013 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google